+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peripheral Vascular Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 166 Pages
  • October 2021
  • Region: Global
  • GlobalData
  • ID: 5459999
Description Jump to:
Peripheral Vascular Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Summary


This Medical Devices sector report, “Peripheral Vascular Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Peripheral Vascular Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A peripheral vascular stent is an expandable perforated tube which is inserted into a peripheral vessel to prevent blood flow constriction. Bare metal stents (BMS), drug eluting stents (DES), covered stents and bio-absorbable stents are covered under this segment. A stent refers to a stent delivery system.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


  • Extensive coverage of the Peripheral Vascular Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Vascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Peripheral Vascular Stents Overview
3 Products under Development
3.1 Peripheral Vascular Stents - Pipeline Products by Stage of Development
3.2 Peripheral Vascular Stents - Pipeline Products by Segment
3.3 Peripheral Vascular Stents - Pipeline Products by Territory
3.4 Peripheral Vascular Stents - Pipeline Products by Regulatory Path
3.5 Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
3.6 Peripheral Vascular Stents - Ongoing Clinical Trials
4 Peripheral Vascular Stents - Pipeline Products under Development by Companies
4.1 Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
4.2 Peripheral Vascular Stents - Pipeline Products by Stage of Development
5 Peripheral Vascular Stents Companies and Product Overview
5.1 3D Biotek LLC Company Overview
5.1.1 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview
5.2 Abbott Vascular Inc Company Overview
5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 AlviMedica Medical Technologies Inc Company Overview
5.3.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 amg International GmbH Company Overview
5.4.1 amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 AndraTec GmbH Company Overview
5.5.1 AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.6 Arterius Ltd Company Overview
5.6.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.7 Biotyx Medical Company Overview
5.7.1 Biotyx Medical Pipeline Products & Ongoing Clinical Trials Overview
5.8 Boston Scientific Corp Company Overview
5.8.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Cardiatis SA Company Overview
5.9.1 Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview
5.10 Cardinal Health Inc Company Overview
5.10.1 Cardinal Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Cook Medical Inc Company Overview
5.11.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Cordis Corp Company Overview
5.12.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 Corinnova Inc Company Overview
5.13.1 Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.14.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.15 Efemoral Medical LLC Company Overview
5.15.1 Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 Efferent Labs Inc Company Overview
5.16.1 Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Electroformed Stents Inc Company Overview
5.17.1 Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Elixir Medical Corp Company Overview
5.18.1 Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.19 FIT Biotech Oy (Inactive) Company Overview
5.19.1 FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.20 ID Nest Medical SAS Company Overview
5.20.1 ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview
5.21 InspireMD Inc Company Overview
5.21.1 InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Kyoto Medical Planning Co Ltd Company Overview
5.22.1 Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.23 LeoMed, LLC Company Overview
5.23.1 LeoMed, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.24 Lepu Medical Technology (Beijing) Co Ltd Company Overview
5.24.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.25 LimFlow SA Company Overview
5.25.1 LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview
5.26 Lyra Therapeutics Inc Company Overview
5.26.1 Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.27 Medtronic Inc Company Overview
5.27.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Meril Life Sciences Pvt Ltd Company Overview
5.28.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.29 Micell Technologies Inc Company Overview
5.29.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.30 Micro Medical Solutions Inc Company Overview
5.30.1 Micro Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 MicroPort Endovascular (Shanghai) Co., Ltd. Company Overview
5.31.1 MicroPort Endovascular (Shanghai) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.32 Natec Medical Ltd Company Overview
5.32.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 Nipro Corp Company Overview
5.33.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
5.34 NSVascular, Inc. Company Overview
5.34.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.35 OrbusNeich Company Overview
5.35.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
5.36 PeriTec Biosciences Ltd Company Overview
5.36.1 PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.37 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.37.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.38 Qvanteq AG Company Overview
5.38.1 Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
5.39 Reflow Medical, Inc. Company Overview
5.39.1 Reflow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.40 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
5.40.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.41 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview
5.41.1 Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.42 Synergy Flow Ltd Company Overview
5.42.1 Synergy Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.43 Taewoong Medical Co Ltd Company Overview
5.43.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.44 Tepha Inc Company Overview
5.44.1 Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
5.45 TissueGen Inc Company Overview
5.45.1 TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
5.46 Tractivus SL Company Overview
5.46.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview
5.47 University of Michigan Company Overview
5.47.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.48 University of Pittsburgh Company Overview
5.48.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.49 University of Pittsburgh Medical Center Company Overview
5.49.1 University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.50 Vascular Bioresorbable Technologies Company Overview
5.50.1 Vascular Bioresorbable Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.51 Vascular Concepts Ltd Company Overview
5.51.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.52 Vascular Dynamics Ltd. Company Overview
5.52.1 Vascular Dynamics Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.53 Vesper Medical Inc Company Overview
5.53.1 Vesper Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.54 Vinnova Company Overview
5.54.1 Vinnova Pipeline Products & Ongoing Clinical Trials Overview
5.55 VueKlar Cardiovascular Ltd (Inactive) Company Overview
5.55.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.56 Wake Forest University Health Sciences Company Overview
5.56.1 Wake Forest University Health Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.57 Xenogenics Corporation Company Overview
5.57.1 Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.58 Zorion Medical Company Overview
5.58.1 Zorion Medical Pipeline Products & Ongoing Clinical Trials Overview
5.59 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
5.59.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Peripheral Vascular Stents- Recent Developments
6.1 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
6.2 Sep 23, 2021: Neovasc to Participate in 2021 Benzinga Healthcare Small Cap Conference
6.3 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021
6.4 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.5 Aug 10, 2021: Neovasc Announces Second Quarter 2021 Financial Results
6.6 Aug 05, 2021: Olympus Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2022
6.7 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.8 Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021
6.9 Jul 29, 2021: Edwards Lifesciences Announces financial results for the quarter ended June 30, 2021
6.10 Jul 28, 2021: CONMED Announces financial results for the second quarter ended June 30, 2021
6.11 Jul 27, 2021: Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
6.12 Jul 22, 2021: Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
6.13 Jul 13, 2021: AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
6.14 Jul 13, 2021: Neovasc Announces New Appointments in Regulatory and Clinical Leadership
6.15 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
6.16 Jun 03, 2021: Neovasc Reports Results of Annual General Meeting of Shareholders
6.17 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.18 May 06, 2021: Neovasc Announces First Quarter 2021 Financial Results
6.19 May 05, 2021: Edwards Announces Updates From Annual Meeting
6.20 Apr 28, 2021: CONMED Announces First Quarter Financial Results
6.21 Apr 01, 2021: CONMED to Announce First Quarter 2021 Financial Results on April 28, 2021
6.22 Mar 30, 2021: AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
6.23 Mar 29, 2021: Merit Medical Reports Results for Quarter Ended March 31, 2021
6.24 Mar 23, 2021: CONMED Announces Annual Meeting of Stockholders
6.25 Mar 11, 2021: Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
6.26 Mar 03, 2021: Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
6.27 Mar 01, 2021: AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
6.28 Feb 17, 2021: Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference
6.29 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.30 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.31 Feb 16, 2021: CONMED Corporation to Participate in a Virtual Fireside Chat at the SVB Leerink Global Healthcare Conference
6.32 Feb 12, 2021: Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021
6.33 Feb 12, 2021: Olympus reports 9M results
6.34 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.35 Feb 10, 2021: Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference
6.36 Feb 04, 2021: Terumo announce Financial Statements
6.37 Jan 13, 2021: Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021
6.38 Jan 07, 2021: Merit Medical to Participate in Two Upcoming Investor Conferences
6.39 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings
6.40 Jan 04, 2021: AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
6.41 Jan 04, 2021: Neovasc Announces Participation in H.C. Wainwright BioConnect 2021 Virtual Conference
6.42 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience
6.43 Oct 23, 2020: Mentice receives order of total SEK 7.1 million from ABBOTT
6.44 Oct 22, 2020: Neovasc to Report Third Quarter Financial Results on November 5, 2020
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • Peripheral Vascular Stents - Pipeline Products by Segment
  • Peripheral Vascular Stents - Pipeline Products by Territory
  • Peripheral Vascular Stents - Pipeline Products by Regulatory Path
  • Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
  • Peripheral Vascular Stents - Ongoing Clinical Trials
  • Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
  • Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Status
  • Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Description
  • Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • ESPRIT Bioresorbable Vascular Scaffold - Product Status
  • ESPRIT Bioresorbable Vascular Scaffold - Product Description
  • ESPRIT BTK Bioresorbable Vascular Scaffold - Product Status
  • ESPRIT BTK Bioresorbable Vascular Scaffold - Product Description
  • Abbott Vascular Inc - Ongoing Clinical Trials Overview
  • ESPRIT BTK Bioresorbable Vascular Scaffold - LIFE-BTK (Pivotal Investigation of Safety and Efficacy of BRS Treatment-below the Knee) Randomized Controlled Trial
  • AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Cre8 BTK - Product Status
  • Cre8 BTK - Product Description
  • Easy Flype - Product Status
  • Easy Flype - Product Description
  • Easy HiFlype - Product Status
  • Easy HiFlype - Product Description
  • Isthmus Logic - Product Status
  • Isthmus Logic - Product Description
  • NiTiDES - Product Status
  • NiTiDES - Product Description
  • amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • UNITY-B Peripheral Stent - Product Status
  • UNITY-B Peripheral Stent - Product Description
  • AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Pillar Bifurcation Reconstruction Device - Product Status
  • Pillar Bifurcation Reconstruction Device - Product Description
  • Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Arteriosorb Absorbable Drug-Eluting Scaffold - Product Status
  • Arteriosorb Absorbable Drug-Eluting Scaffold - Product Description
  • Bioresorbable Stent - Peripheral Vascular Disease - Product Status
  • Bioresorbable Stent - Peripheral Vascular Disease - Product Description
  • Biotyx Medical Pipeline Products & Ongoing Clinical Trials Overview
  • IBS Titan - Product Status
  • IBS Titan - Product Description
  • Biotyx Medical - Ongoing Clinical Trials Overview
  • IBS Titan - A Prospective, Multi-Center, Randomized Trial Comparing the IBS Titan Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System vs. Standard Balloon Angioplasty for Treatment of Below-the-Knee Arteries: GENIUS TRIAL
  • Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Eluvia Drug-Eluting Vascular Stent System - Product Status
  • Eluvia Drug-Eluting Vascular Stent System - Product Description
  • SAVAL Drug Eluting Stent BTK - Product Status
  • SAVAL Drug Eluting Stent BTK - Product Description
  • Symbiot Covered Stent System - Product Status
  • Symbiot Covered Stent System - Product Description
  • Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Status
  • Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Description
  • Boston Scientific Corp - Ongoing Clinical Trials Overview
  • Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
  • Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Zilver PTX Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
  • Eluvia Drug-Eluting Vascular Stent System - A Real World Evaluation of the ELUVIA Drug Eluting Stent in All-comers with Superficial Femoral Artery and Proximal Popliteal Artery Disease
  • Eluvia Drug-Eluting Vascular Stent System - Drug-eluting Registry: Real-world Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
  • Eluvia Drug-Eluting Vascular Stent System - Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
  • Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Sinai Vein Stent Registry
  • SAVAL Drug Eluting Stent BTK - A Randomized Trial Comparing the Drug-eluting Stent (DES) Below-the-knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) Versus Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects with Critical Limb Ischemia
  • Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview
  • Cardiatis FluidSmart 3D Stent - Product Status
  • Cardiatis FluidSmart 3D Stent - Product Description
  • Cardinal Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Palmaz-Mullins XD - Product Status
  • Palmaz-Mullins XD - Product Description
  • Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Zenith Connection Endovascular Covered Stent - Product Status
  • Zenith Connection Endovascular Covered Stent - Product Description
  • Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
  • FlexStent Self Expanding Below-The-Knee Venous Stent System - Product Status
  • FlexStent Self Expanding Below-The-Knee Venous Stent System - Product Description
  • FlexStent Self Expanding Venous Stent System - Product Status
  • FlexStent Self Expanding Venous Stent System - Product Description
  • Tibial SE FlexStent - Product Status
  • Tibial SE FlexStent - Product Description
  • Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Hybrid Dynamic Stent - Product Status
  • Hybrid Dynamic Stent - Product Description
  • Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • LifeJacket Stent Graft - Peripheral - Product Status
  • LifeJacket Stent Graft - Peripheral - Product Description
  • Efemoral Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Efemoral Device - Product Status
  • Efemoral Device - Product Description
  • Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
  • RTI-LICD Plexisense - Product Status
  • RTI-LICD Plexisense - Product Description
  • Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Helical Stent - Product Status
  • Helical Stent - Product Description
  • Patch Stent - Product Status
  • Patch Stent - Product Description
  • Pleated Stent - Product Status
  • Pleated Stent - Product Description
  • Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • PRAVA Bioresorbable Scaffold - Product Status
  • PRAVA Bioresorbable Scaffold - Product Description
  • FIT Biotech Oy (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • GTU X-Stent - Product Status
  • GTU X-Stent - Product Description
  • GTU X2-Stent - Product Status
  • GTU X2-Stent - Product Description
  • ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview
  • ID Venous System - Product Status
  • ID Venous System - Product Description
  • InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
  • PVGuard Peripheral - Product Status
  • PVGuard Peripheral - Product Description
  • Kyoto Medical Planning Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • REMEDY - Drug Eluting - Product Status
  • REMEDY - Drug Eluting - Product Description
  • REMEDY - New Version - Product Status
  • REMEDY - New Version - Product Description
  • LeoMed, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Peripheral Arterial Stent - Product Status
  • Peripheral Arterial Stent - Product Description
  • Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Bare Stent - Product Status
  • Bare Stent - Product Description
  • LimFlow SA Pipeline Products & Ongoing Clinical Trials Overview
  • LimFlow Percutaneous Deep Vein Arterialisation System - Product Status
  • LimFlow Percutaneous Deep Vein Arterialisation System - Product Description
  • LimFlow SA - Ongoing Clinical Trials Overview
  • LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization for the Treatment of Late-stage Chronic Limb-threatening Ischemia: The PROMISE II Trial
  • LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization Post-market Study
  • LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization Post-market Study
  • LimFlow Percutaneous Deep Vein Arterialisation System - Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System for Creating an AV Fistula for the Treatment of Critical Limb Ischemia
  • Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Stanza Bioresorbable Pediatric Scaffold - Product Status
  • Stanza Bioresorbable Pediatric Scaffold - Product Description
  • Stanza Bioresorbable Self-Expanding Scaffold - Product Status
  • Stanza Bioresorbable Self-Expanding Scaffold - Product Description
  • Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
  • RADIANT - Product Status
  • RADIANT - Product Description
  • Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Credence BRS - Product Status
  • Credence BRS - Product Description
  • Interlace BRS - Product Status
  • Interlace BRS - Product Description
  • Melange BRS - Product Status
  • Melange BRS - Product Description
  • Meril Life Sciences Pvt Ltd - Ongoing Clinical Trials Overview
  • Credence BRS - To evaluate safety and performance of CREDENCE BRS Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with de novo native peripheral artery lesions
  • Melange BRS - A Prospective, Multicentre, Open Label Clinical Study to Evaluate Safety and Performance of Melange BRS Sirolimus Eluting Bioresorbable Peripheral Scaffold System for Use as an Adjunct to Percutaneous Transluminal Renal Angioplasty of Atherosclerotic De Novo or Restenotic Lesion of the Renal Artery
  • Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Peripheral Drug-Eluting Stent - Product Status
  • Peripheral Drug-Eluting Stent - Product Description
  • Micro Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
  • MicroStent - Product Status
  • MicroStent - Product Description
  • Micro Medical Solutions Inc - Ongoing Clinical Trials Overview
  • MicroStent - A Clinical Evaluation of the MicroStent Peripheral Vascular Stent in Subjects with Arterial Disease below the Knee: STAND
  • MicroStent - An All-comers Observational Study of the MicroStent Peripheral Vascular Stent System in Subjects with Peripheral Arterial Disease
  • MicroPort Endovascular (Shanghai) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Venous Stent - Product Status
  • Venous Stent - Product Description
  • Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Marina - Product Status
  • Marina - Product Description
  • Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Peripheral Stent - Product Status
  • Peripheral Stent - Product Description
  • NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Micropatterned TFN Stent - Product Status
  • Micropatterned TFN Stent - Product Description
  • OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
  • Small Vessel - BTA - Product Status
  • Small Vessel - BTA - Product Description
  • PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Periteneum-Lined Balloon-Expandable Stent - Product Status
  • Periteneum-Lined Balloon-Expandable Stent - Product Description
  • Peritoneum Lined Self-Expanding Stent - Product Status
  • Peritoneum Lined Self-Expanding Stent - Product Description
  • QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • SOZO With 0.014 PERSEUS-q PTA Balloon Catheter - Product Status
  • SOZO With 0.014 PERSEUS-q PTA Balloon Catheter - Product Description
  • Tracheobronchial Stent - Product Status
  • Tracheobronchial Stent - Product Description
  • Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview
  • Qstent Peripheral Stent - Product Status
  • Qstent Peripheral Stent - Product Description
  • Reflow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Temporary Spur Stent System - Product Status
  • Temporary Spur Stent System - Product Description
  • Reflow Medical, Inc. - Ongoing Clinical Trials Overview
  • Temporary Spur Stent System - A Non-randomized Pilot Study of the Temporary Spur Stent System for the Treatment of Lesions Located in the Infrapopliteal Arteries Using a LIMUS-base Drug-coated Balloon (DEEPER LIMUS)
  • Temporary Spur Stent System - A Non-randomized Trial of the Temporary Spur Stent System for the Treatment of Lesions Located in the Infrapopliteal Arteries Outside of the United States
  • Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Iliac Vein Stent - Product Status
  • Iliac Vein Stent - Product Description
  • Lower Limb Arterial Drug-Loaded Stent - Product Status
  • Lower Limb Arterial Drug-Loaded Stent - Product Description
  • Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Iliac Vein Stent System - Product Status
  • Iliac Vein Stent System - Product Description
  • Synergy Flow Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • ArtiStent - Product Status
  • ArtiStent - Product Description
  • Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Niti-S Nagi Stent - Product Status
  • Niti-S Nagi Stent - Product Description
  • Taewoong Medical Co Ltd - Ongoing Clinical Trials Overview
  • Niti-S Nagi Stent - A Randomized Control Trial of Plastic Stents Vs. Nagi Bi-flanged Metal Stent for Endoscopic Ultrasound Guided Drainage of Walled-off Necrosis
  • Tepha Inc Pipeline Products & Ongoing Clinical Trials Overview
  • TephaFLEX Fully Absorbable Peripheral Stent - Product Status
  • TephaFLEX Fully Absorbable Peripheral Stent - Product Description
  • TissueGen Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Archer Stent - Product Status
  • Archer Stent - Product Description
  • Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview
  • Bacteriaphobic Tracheal Stent - Product Status
  • Bacteriaphobic Tracheal Stent - Product Description
  • University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • Tracheal Stent - Product Status
  • Tracheal Stent - Product Description
  • University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
  • Dual Chamber Stent - Product Status
  • Dual Chamber Stent - Product Description
  • University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Retrievable Vascular Stent - Product Status
  • Retrievable Vascular Stent - Product Description
  • Vascular Bioresorbable Technologies Pipeline Products & Ongoing Clinical Trials Overview
  • Drug Eluting Scaffold - Peripheral Artery Disease - Product Status
  • Drug Eluting Scaffold - Peripheral Artery Disease - Product Description
  • Drug Free Pure Bioresorbable Scaffold - Peripheral Artery Disease - Product Status
  • Drug Free Pure Bioresorbable Scaffold - Peripheral Artery Disease - Product Description
  • Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Covered Peripheral Stent - Product Status
  • Covered Peripheral Stent - Product Description
  • Prograft SX - Product Status
  • Prograft SX - Product Description
  • Vascular Dynamics Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • MobiusHD Device - Product Status
  • MobiusHD Device - Product Description
  • Vascular Dynamics Ltd. - Ongoing Clinical Trials Overview
  • MobiusHD Device - A Feasibility Study Exploring the Effect of the MobiusHD in Patients with Heart Failure
  • MobiusHD Device - Controlling and Lowering Blood Pressure with the MobiusHD - A Prospective Multicenter Safety Study: CALM-FIM_US
  • MobiusHD Device - Controlling and Lowering Blood Pressure with the MobiusHD - Defining Efficacy Markers
  • MobiusHD Device - Controlling and Lowering Blood Pressure with the MobiusHD Device: Studying Effects in a Randomized Trial: CALM-START
  • MobiusHD Device - Controlling and Lowering Blood Pressure with the MobiusHD: CALM- 2
  • Vesper Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Vesper Duo Venous Stent System - Product Status
  • Vesper Duo Venous Stent System - Product Description
  • Vesper Medical Inc - Ongoing Clinical Trials Overview
  • Vesper Duo Venous Stent System - Venous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System
  • Vinnova Pipeline Products & Ongoing Clinical Trials Overview
  • Grency Venous Stent System - Product Status
  • Grency Venous Stent System - Product Description
  • VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • MR-Enhancing Balloon Expandable Stent - Product Status
  • MR-Enhancing Balloon Expandable Stent - Product Description
  • MR-Enhancing Self-Expanding Stent - Product Status
  • MR-Enhancing Self-Expanding Stent - Product Description
  • Wake Forest University Health Sciences Pipeline Products & Ongoing Clinical Trials Overview
  • Vascular Stent - Product Status
  • Vascular Stent - Product Description
  • Xenogenics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Ideal BioStent - Peripheral - Product Status
  • Ideal BioStent - Peripheral - Product Description
  • Unison Peripheral Stent System - Product Status
  • Unison Peripheral Stent System - Product Description
  • Zorion Medical Pipeline Products & Ongoing Clinical Trials Overview
  • ZMED Absorbable Drug Eluting Stent - Product Status
  • ZMED Absorbable Drug Eluting Stent - Product Description
  • Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Multi-Segment Stent System - Product Status
  • Multi-Segment Stent System - Product Description
  • Zenflex Peripheral Stent System - Product Status
  • Zenflex Peripheral Stent System - Product Description
  • ZENFLEX Pro Peripheral Drug Eluting Stent System - Product Status
  • ZENFLEX Pro Peripheral Drug Eluting Stent System - Product Description
  • Zylox-Tonbridge Medical Technology Co Ltd - Ongoing Clinical Trials Overview
  • ZENFLEX Pro Peripheral Drug Eluting Stent System - Swedish Drug-elution Trial in Peripheral Arterial Disease - A Multicenter, Prospective Randomized Controlled Clinical Trial Based on the Swedish Vascular Registry (SWEDVASC) Platform
  • ZENFLEX Pro Peripheral Drug Eluting Stent System - The Safety and Efficacy of Drug Eluting Peripheral Vascular Stent System for the Treatment of Superficial Femoral Artery Stenosis and /or Occlusion: A Multi-center Stratified Randomized Single-blind Controlled Trial
  • Zenflex Peripheral Stent System - ZENFlex-registry to Evaluate the Outcome of Bare Metal Stent-assisted Angioplasty in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
  • Glossary

List of Figures
  • Peripheral Vascular Stents - Pipeline Products by Stage of Development
  • Peripheral Vascular Stents - Pipeline Products by Segment
  • Peripheral Vascular Stents - Pipeline Products by Territory
  • Peripheral Vascular Stents - Pipeline Products by Regulatory Path
  • Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
  • Peripheral Vascular Stents - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3D Biotek LLC
  • Abbott Vascular Inc
  • AlviMedica Medical Technologies Inc
  • amg International GmbH
  • AndraTec GmbH
  • Arterius Ltd
  • Biotyx Medical
  • Boston Scientific Corp
  • Cardiatis SA
  • Cardinal Health Inc
  • Cook Medical Inc
  • Cordis Corp
  • Corinnova Inc
  • Cytograft Tissue Engineering Inc (Inactive)
  • Efemoral Medical LLC
  • Efferent Labs Inc
  • Electroformed Stents Inc
  • Elixir Medical Corp
  • FIT Biotech Oy (Inactive)
  • ID Nest Medical SAS
  • InspireMD Inc
  • Kyoto Medical Planning Co Ltd
  • LeoMed, LLC
  • Lepu Medical Technology (Beijing) Co Ltd
  • LimFlow SA
  • Lyra Therapeutics Inc
  • Medtronic Inc
  • Meril Life Sciences Pvt Ltd
  • Micell Technologies Inc
  • Micro Medical Solutions Inc
  • MicroPort Endovascular (Shanghai) Co., Ltd.
  • Natec Medical Ltd
  • Nipro Corp
  • NSVascular, Inc.
  • OrbusNeich
  • PeriTec Biosciences Ltd
  • QualiMed Innovative Medizinprodukte GmbH
  • Qvanteq AG
  • Reflow Medical, Inc.
  • Shenzhen Salubris Pharmaceuticals Co Ltd
  • Suzhou Tianhong Shengjie Medical Co Ltd
  • Synergy Flow Ltd
  • Taewoong Medical Co Ltd
  • Tepha Inc
  • TissueGen Inc
  • Tractivus SL
  • University of Michigan
  • University of Pittsburgh
  • University of Pittsburgh Medical Center
  • Vascular Bioresorbable Technologies
  • Vascular Concepts Ltd
  • Vascular Dynamics Ltd.
  • Vesper Medical Inc
  • Vinnova
  • VueKlar Cardiovascular Ltd (Inactive)
  • Wake Forest University Health Sciences
  • Xenogenics Corporation
  • Zorion Medical
  • Zylox-Tonbridge Medical Technology Co Ltd

Related Topics

Related Reports

Vascular Stent Global Market Report 2024 - Product Image

Vascular Stent Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Vascular Stents Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Vascular Stents Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 150 Pages
  • Global
From
Global Vascular Stents Market Report and Forecast 2023-2031 - Product Image

Global Vascular Stents Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Vascular Stents Market Report by Product Type, Material, Mode of Delivery, End-User, and Region 2024-2032 - Product Image

Vascular Stents Market Report by Product Type, Material, Mode of Delivery, End-User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Peripheral Vascular Stents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031 - Product Image

Peripheral Vascular Stents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031

  • Report
  • 116 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.